BUZZ-Abbott rises after raising annual profit forecast on heart device demand

Abbott Laboratories

Abbott Laboratories

ABT

0.00

** Shares of Abbott Laboratories ABT.N up 2.43% at $91.44 premarket

** Co raises 2026 adjusted profit forecast to $5.45-$5.60/shr from prior view of $5.38-$5.58/shr, above analysts' average estimate of $5.49/shr - LSEG data

** Demand for Abbott's heart devices expected to remain strong in the second half of the year, ABT says

** Co reports Q2 adj. profit of $1.31/shr vs estimates of $1.28/shr

** Co's quarterly revenue of $12.6 billion beats expectations of $12.5 billion

** As of last close, stock down ~29% YTD


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.